New product approved in US for haemophilia A
The FDA has recently approved the Wyeth product Xyntha™ for the control and prevention of bleeding episodes and for surgical prophylaxis in patients diagnosed with haemophilia A.
See here for more details
The FDA has recently approved the Wyeth product Xyntha™ for the control and prevention of bleeding episodes and for surgical prophylaxis in patients diagnosed with haemophilia A.
See here for more details
